Ganciclovir Sodium Tenders

corporations/Associations/Others

Tender For corrigendum : e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1mg [159], atropine eye ointment ip 1%[319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500mg ip [529], inj. d-selected">ganciclovir d-selected">sodium 500mg (lyophilized powder forreconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant fviii 250 iuwith diluent [749], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension[nrd-103], hpmc 0.3%eye drop [nrd-104], chloramphenic ol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% d-selected">sodium phosphate eye ointment[nrd-123], cabazitaxel injection 60 mg [nrd-167], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mginj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisol one acetate 125 mg i.p. (each vial contains methylprednisol one acetate 125mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd-387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule[nrd-794], ulipristal 5mg tab. [nrd-808], black disinfectant fluid (phenyl) as per scheduleo grade iii [398], phenobarbitone inj ip 200mg/ml [420], piperacillin + tazobactum for injection ip 4gm+500mg[468], decitabine 50 mg inj. [nrd-207], levosalbutamol 50mcg. and ipratropium40mcg. mdi [nrd-425], glycopegylated extended half life factor viii 1000 iu

corporations/Associations/Others

Tender For short term e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50 mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1 mg [159], atropine eye ointment ip 1% [319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500 mg ip [529], inj. d-selected">ganciclovir d-selected">sodium 500mg (lyophilized powder for reconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant f viii 250 iu with diluent [749], brinozolamide 1% w/v and brimonidine tartrate 0.2% w/v ophthalmic suspension [nrd-98], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103], hpmc 0.3% eye drop [nrd-104], proparacaine 0.5% w/v eye drop usp [nrd-114], voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119], chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% d-selected">sodium phosphate eye ointment [nrd-123], cabazitaxel injection 60 mg [nrd-167], carmustine 100 mg inj. ip [nrd-175], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mg inj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylprednisolone acetate 125 mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], rasburicase 1.5 mg inj. [nrd-347], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd- 387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule [nrd-794], ulipristal 5mg tab. [nrd-808], glycopegylated extended half life factor viii 1000 iu